Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients

Jayme E Locke, Andrew L SingerJohns Hopkins Medical Institutions, Department of Surgery, Division of Transplantation, Baltimore, MD, USAAbstract: The introduction of calcineurin inhibitor (CNI) based immunosuppression has revolutionized the field of liver transplantation by dramatically reducing the...

Full description

Bibliographic Details
Main Authors:	Locke JE, Singer AL
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-05-01
Series:	Hepatic Medicine : Evidence and Research
Online Access:	http://www.dovepress.com/evolving-concepts-in-the-selection-of-immunosuppression-regimen-for-li-a7443

Similar Items

Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
by: Kentaro Ide, et al.
Published: (2011-01-01)

Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid
by: Sanjaya K. Satapathy, MBBS, MD, DM, et al.
Published: (2017-07-01)

Belatacept as salvage maintenance immunosuppression in a liver transplant recipient
by: Kyle Lang, et al.
Published: (2020-12-01)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
by: Koen G. A. M. Hussaarts, et al.
Published: (2021-01-01)

Elevated Incidence of Fractures in Solid-Organ Transplant Recipients on Glucocorticoid-Sparing Immunosuppressive Regimens
by: B. J. Edwards, et al.
Published: (2011-01-01)

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
by: Kirby Sean, et al.
Published: (2012-03-01)

Patient involvement in selection of immunosuppressive regimen following transplantation
by: Popoola J, et al.
Published: (2014-12-01)

Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients
by: Liu FC, et al.
Published: (2017-08-01)

Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales
by: Muduma G, et al.
Published: (2014-11-01)

Factors associated with adherence of immunosuppressive therapy among liver and kidney transplant recipients
by: Ming-hui Shin, et al.
Published: (2012)

Effects of immunosuppressive regimens with cyclosporine and other risk factors on bone mineral density in cardiac transplant recipients.
by: Kuo Hsin Lei, et al.
Published: (2003)

Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.
by: Yuan-Yuan Liu, et al.
Published: (2015-01-01)

Retraction: Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression.
by: PLOS ONE Editors
Published: (2019-01-01)

Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients
by: M. Sh Khubutia, et al.
Published: (2016-01-01)

The role of basiliximab in the evolving renal transplantation immunosuppression protocol
by: Paola Salis, et al.
Published: (2008-06-01)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
by: Katherine A. Barraclough, et al.
Published: (2011-01-01)

Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient
by: Danae Olaso, et al.
Published: (2021-08-01)

Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
by: Jong Man Kim, et al.
Published: (2016-09-01)

Individualized Immunosuppressive Protocol of Liver Transplant Recipient Should be Made Based on Splenic Function Status
by: Ji-Yong Song, et al.
Published: (2016-01-01)

Liver Transplantation: Evolving Patient Selection Criteria
by: Andy S Yu, et al.
Published: (2001-01-01)

Transplantation: Polyomavirus Nephropathy and the Risk of Specific Immunosuppression Regimens
by: Christine Wu, et al.
Published: (2006-01-01)

Improvement of medication adherence with simplified once-daily immunosuppressive regimen in stable kidney transplant recipients: A prospective cohort study
by: Chang-Kwon Oh, et al.
Published: (2020-06-01)

Modulation of maintenance immunosuppression during infection in renal transplant recipients
by: M Edwin Fernando, et al.
Published: (2018-01-01)

Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen.
by: Gianluigi Zaza, et al.
Published: (2017-01-01)

A case of rhabdomyolysis after atorvastatin therapy of a liver transplant recipient receiving immunosuppressive therapy with cyclosporine
by: A. V. Shabunin, et al.
Published: (2021-06-01)

Potential Effects of Immunosuppression on Oxidative Stress and Atherosclerosis in Kidney Transplant Recipients
by: Marlena Kwiatkowska, et al.
Published: (2021-01-01)

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
by: Mysore K. Phanish, et al.
Published: (2020-03-01)

Neutropenic Enterocolitis in a Pediatric Heart Transplant Recipient on Multiple Immunosuppressants
by: Emily E. Miller, et al.
Published: (2018-01-01)

Switching Immunosuppressive Drugs in Kidney Transplant Recipients: "Show Me the Evidence"
by: Ansari Mohammed, et al.
Published: (2006-01-01)

Prevalence and psychosocial correlates of non-adherence to immunosuppressants in renal transplant recipients
by: Butler, Janet Ann
Published: (2003)

An assessment of adherence to immunosuppressive therapy and impact factors in renal transplant recipients
by: Ching-Yao Cheng, et al.
Published: (2011)

Early Introduction of Everolimus Immunosuppressive Regimen in Liver Transplantation with Extra-Anatomic Aortoiliac-Hepatic Arterial Graft Anastomosis
by: Emanuele Felli, et al.
Published: (2014-01-01)

The Portuguese Version of the Immunosuppressant Therapy Adherence Scale (ITAS) among Liver Transplant Recipient Patients: Translation and Psychometric Properties
by: Ana Paula Jesus-Nunes, et al.
Published: (2018-01-01)

Efficacy and Safety of Low-Dose Everolimus as Maintenance Immunosuppression in Cardiac Transplant Recipients
by: Uwe Fuchs, et al.
Published: (2012-01-01)

Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in “Omics” Medicine
by: Gianluigi Zaza, et al.
Published: (2015-02-01)

Factors Associated With Adherence To Immunosuppressive Therapy And Barriers In Asian Kidney Transplant Recipients
by: Ganjali R, et al.
Published: (2019-11-01)

Fatal complications of long-term immunosuppressive therapy in a renal transplant recipient
by: I G Rekhtina, et al.
Published: (2008-07-01)

Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen
by: Mirjalili M, et al.
Published: (2020-07-01)

Fungal Infections in Liver Transplant Recipients
by: Michael Scolarici, et al.
Published: (2021-06-01)

Gut microbiota of liver transplantation recipients
by: Li-Ying Sun, et al.
Published: (2017-06-01)

Cannot write session to /tmp/vufind_sessions/sess_sikdulsfckke16fo5sblqtgkp5